Amgen, Inc. Recall: AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard un
Amgen, Inc. Recall: AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard un is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Amgen, Inc.; Product: AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx O
| Recalling firm | Amgen, Inc. |
|---|---|
| Product | AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01 |
| Reason for recall | Lack of Assurance of Sterility: Potential cracks in glass vials |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | United States and Puerto Rico No foreign distribution. |
| Recall initiated | 20161215 |
| Recall number | D-0226-2017 |
| Category | drug |
| State | CA |
| Country | United States |
$29/mo
Try RecallGuard →